Skip to main content

Table 1 Patient and disease characteristics

From: Multicenter phase II study of weekly docetaxel, cisplatin, and S-1 (TPS) induction chemotherapy for locally advanced squamous cell cancer of the head and neck

Characteristics

Number (%)

Total patients

35

Age (years)

 

 Median ± SD

57.4 ± 9.5

Sex

 

 Male

33 (94.3)

 Female

2 (5.7)

ECOG Performance status

 

 0

17 (48.6)

 1

17 (48.6)

 2

1 (2.9)

Tumor (T)

 

 T1

3 (8.6)

 T2

16 (45.7)

 T3

9 (25.7)

 T4

7 (20.0)

Lymph node (N)

 

 N0

3 (8.6)

 N1

6 (17.1)

 N2

24 (68.6)

 N3

2 (5.7)

AJCC/UICC staging system

 

 III

7 (20.0)

 IVA

25 (71.4)

 IVB

3 (8.6)

Primary tumor site

 

 Oropharnyx

17 (48.6)

 Hypopharynx

10 (28.6)

 Larynx

8 (22.9)